Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sai Kiran Mavileti"'
Publikováno v:
Biosensors, Vol 14, Iss 10, p 458 (2024)
Trypsin enzyme has gained recognition as a potential biomarker in several tumors, such as colorectal, gastric, and pancreatic cancer, highlighting its importance in disease diagnosis. In response to the demand for rapid, cost-effective, and real-time
Externí odkaz:
https://doaj.org/article/c8e09d55ceed4c6891a0a665d1347039
Publikováno v:
Molecules, Vol 29, Iss 6, p 1282 (2024)
Chymotrypsin, a crucial enzyme in human digestion, catalyzes the breakdown of milk proteins, underscoring its significance in both health diagnostics and dairy quality assurance. Addressing the critical need for rapid, cost-effective detection method
Externí odkaz:
https://doaj.org/article/ab545be92abf4920b879b8856e5d0f5d
Autor:
Nitesh Tamang, Sai Kiran Mavileti, Mamta Yadav, Srinivas Nanduri, Dinkar Sahal, Nageswara Rao Golakoti
Publikováno v:
Chemical Papers. 77:3015-3023
Autor:
Nitesh Tamang, Christopher Andrews, Sai Kiran Mavileti, Srinivas Nanduri, Nageswara Rao Golakoti, Balasubramanyam Karanam
Publikováno v:
New J Chem
Acetals (2a–d, 3a–d, and 6a–d) of andrographolide (1), 14-deoxy-12-hydroxyandrographolide (4), and isoandrographolide (5) were synthesized using benzaldehyde and heteroaromatic aldehydes. All the synthesized derivatives were characterized using
Autor:
Hariharan Moorthy, Mamta Yadav, Nitesh Tamang, Sai Kiran Mavileti, Labhini Singla, Angshuman Roy Choudhury, Dinkar Sahal, Nageswara Rao Golakoti
Publikováno v:
ChemMedChem.
A series of 22 different 3,5-diarylidenetetrahydro-2H-pyran-4(3H)-ones (DATPs) were synthesized, characterized, and screened for their in vitro antiplasmodial activities against chloroquine (CQ)-sensitive Pf3D7, CQ-resistant PfINDO, and artemisinin-r
Autor:
Sai Kiran Mavileti, Lokanath Neratur Krishnappagowda, Nageswara Rao Golakoti, Mukesh Doble, Gayathri Ramamoorthy, Kartik Mitra, Mahesha, Naveen Shivalingegowda, Swayamsiddha Kar
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 30:127199
Spirobibenzopyrans are an unexplored class of therapeutics. We report the anticancer activity of novel spirobibenzopyrans, synthesized by a one-pot reaction and extensively characterized. Structure of one of the spirobibenzopyran has been determined